Company / R&D Expense
Phibro Animal Health R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$23.7M
FY2025
5-year range
$17.8M / $29.2M
FY2021-FY2025
Trend
-18.7%
vs FY2024
Sector context
#195 of 210
Health Care
What the data says
Among 210 Health Care companies, Phibro Animal Health is in the bottom 7% for r&d expense. R&D Expense has fluctuated over the past 10 years, ranging from $9M in FY2017 to $29M in FY2024.
Based on SEC 10-K filings.
$24M in FY2025 with a 5-year CAGR of +11.5%.
Improved from $18M to $24M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +4.4%
- 5-Year CAGR
- +11.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 210This company $23.7M Sector average $644.0M
▼
-96.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.5%, indicating consistent growth.
- In FY2025, r&d expense decreased 18.7% year-over-year.
- Ranks #195 out of 210 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2024.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.7M | -18.7% |
| FY2024 | $29.2M | +64.4% |
| FY2023 | $17.8M | -14.8% |
| FY2022 | $20.8M | +17.3% |
| FY2021 | $17.8M | +29.3% |
| FY2020 | $13.7M | +13.6% |
| FY2019 | $12.1M | +9.6% |
| FY2018 | $11.0M | +16.8% |
| FY2017 | $9.4M | -14.4% |
| FY2016 | $11.0M | +66.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026